Skandinaviska Enskilda Banken AB publ trimmed its position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 3.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,483,374 shares of the company’s stock after selling 58,988 shares during the quarter. DocuSign makes up approximately 0.6% of Skandinaviska Enskilda Banken AB publ’s holdings, making the stock its 29th largest position. Skandinaviska Enskilda Banken AB publ owned 0.73% of DocuSign worth $136,025,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in DOCU. Kestra Investment Management LLC bought a new position in shares of DocuSign in the 4th quarter worth about $30,000. First Horizon Advisors Inc. boosted its stake in DocuSign by 102.6% in the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after acquiring an additional 201 shares during the period. Modus Advisors LLC bought a new position in shares of DocuSign during the fourth quarter valued at approximately $36,000. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign during the 3rd quarter worth approximately $28,000. Finally, Avion Wealth lifted its holdings in shares of DocuSign by 309.2% in the 4th quarter. Avion Wealth now owns 487 shares of the company’s stock worth $43,000 after purchasing an additional 368 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Buying and Selling
In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares of the company’s stock, valued at $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the completion of the transaction, the director now directly owns 150,253 shares in the company, valued at $13,712,088.78. This represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 104,422 shares of company stock worth $9,665,394 in the last ninety days. 1.66% of the stock is currently owned by corporate insiders.
DocuSign Trading Up 0.8 %
Wall Street Analyst Weigh In
A number of research firms have issued reports on DOCU. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research note on Tuesday, February 4th. Robert W. Baird lifted their price objective on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. UBS Group upped their target price on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $92.91.
Get Our Latest Stock Analysis on DocuSign
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- How to Invest in Small Cap Stocks
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Best Stocks Under $10.00
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.